Retatrutide
Public supplier report and marketplace listing from UWA Biotech.
Supplier testing information
Product overview
Retatrutide is a next-generation investigational peptide supplied by UWA Biotech for laboratory studies involving metabolic regulation, peptide signalling pathways and advanced research applications. This listing is available in wholesale box configurations with multiple vial strengths.
Available formats
- 10 × 20mg (200mg total)
- 10 × 30mg (300mg total)
- MOQ: 10 vials / 1 box
- Supplier: UWA Biotech
Verification
- Purity: 99.692%–99.808%
- Tested: 08 JAN 2026
- Task number: #97490
- Unique key: I1X2VVFWT3UM
Supply details
- Supplier: UWA Biotech
- Location: United States
- Formats: 20mg and 30mg options
- Packaging: Wholesale 10-vial boxes
This product is supplied exclusively for laboratory research use. Not for human consumption, medical treatment or clinical application.
Retatrutide laboratory testing questions
What is this Retatrutide report?
This report contains publicly accessible batch testing information for Retatrutide, including task number #97490, reported purity results, and Janoshik-linked laboratory reference data.
Has this Retatrutide batch been laboratory tested?
Yes. This Retatrutide batch includes publicly accessible laboratory testing references, including reported purity result 99.692%–99.808%, task number #97490, and laboratory reference key I1X2VVFWT3UM.
Who supplied this Retatrutide batch?
UWA Biotech supplied this Retatrutide batch from United States, with public batch testing references and tracked supplier fulfilment information.
What purity was reported for this Retatrutide batch?
The reported purity result for this Retatrutide batch was 99.692%–99.808%.
Where can I view additional Retatrutide reports?
Additional Retatrutide laboratory testing reports and supplier batch references can be viewed through the Buy China Peptides reports directory.